Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 people worldwide and an expertise that spans more than 30 different industries.

今天，提议将传统公司诺维信和Chr合并。汉森成功落成，成立了Novonesis公司。Novonesis是世界领先的生物解决方案合作伙伴，旨在实现更好的商业、更健康的生活和更健康的地球。合并后的公司汇集了全球10000名员工，拥有跨越30多个不同行业的专业知识。

Novonesis is already assisting companies around the world in meeting both business needs and the needs of the planet. COPENHAGEN, Denmark – January 29, 2024. On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.

Novonesis已经在帮助世界各地的公司满足商业需求和地球需求。丹麦哥本哈根——2024年1月29日。2022年12月12日，诺维信和Chr。汉森签署了一项协议，通过两家公司的法定合并创建一个领先的全球生物解决方案合作伙伴。

All regulatory approvals and registrations are now in place and the proposed combination is successfully completed following the final registration with the Danish Business Authority today. Ester Baiget, President and CEO of Novonesis, says: We have successfully combined Novozymes and Chr. Hansen and today we come together as one leading global biosolutions partner.

所有监管部门的批准和注册现已到位，拟议的合并在今天向丹麦商业管理局进行最终注册后成功完成。Novonesis总裁兼首席执行官Ester Baiget表示：我们已经成功地将Novozymes和Chr结合起来。汉森和今天我们作为全球领先的生物解决方案合作伙伴走到了一起。

Novonesis combines our joint strengths and the wonders of biology, and we are set to lead a new era of biosolutions. We will innovate and develop transformative biosolutions that improve the way we all produce, consume and live. And we have gathered the brightest minds and together with my 10,000 colleagues, we will unlock the limitless potential of biosolutions.

Novonesis结合了我们的共同优势和生物学的奇迹，我们将引领生物解决方案的新时代。我们将创新和开发变革性的生物解决方案，以改善我们所有人的生产、消费和生活方式。我们聚集了最聪明的人，与我的10000名同事一起，我们将释放生物解决方案的无限潜力。

Cees de Jong, Chairman of Novonesis, adds: I am pleased to witness the realization of the Novozymes and Chr. Hansen combination, creating a true global biosolutions leader. We will continue to create powerful biosolutions for our customers and partners based on our more than 100 years of innovation and application expertise.

Novonesis董事长Cees de Jong补充道：我很高兴看到Novozymes和Chr的实现。汉森联合，打造真正的全球生物解决方案领导者。基于我们100多年的创新和应用专业知识，我们将继续为我们的客户和合作伙伴创造强大的生物解决方案。

Together, we will serve a.

我们将一起服务。

Attachment

附件

Novonesis day1_Press release

Novonesis day1\u新闻稿